ZOCCOLELLA, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 6.845
EU - Europa 2.325
AS - Asia 1.619
SA - Sud America 395
Continente sconosciuto - Info sul continente non disponibili 263
AF - Africa 90
OC - Oceania 7
Totale 11.544
Nazione #
US - Stati Uniti d'America 6.753
RU - Federazione Russa 827
SG - Singapore 620
IT - Italia 607
CN - Cina 403
BR - Brasile 318
SE - Svezia 191
HK - Hong Kong 184
DE - Germania 164
VN - Vietnam 141
UA - Ucraina 113
GB - Regno Unito 107
FR - Francia 94
FI - Finlandia 93
BD - Bangladesh 69
CA - Canada 51
IN - India 48
CI - Costa d'Avorio 36
NL - Olanda 26
IQ - Iraq 25
TR - Turchia 22
AR - Argentina 20
BE - Belgio 17
JP - Giappone 17
MX - Messico 16
ID - Indonesia 15
ZA - Sudafrica 15
CO - Colombia 14
LT - Lituania 14
PL - Polonia 14
EC - Ecuador 13
IE - Irlanda 10
PK - Pakistan 10
VE - Venezuela 10
CL - Cile 8
SK - Slovacchia (Repubblica Slovacca) 8
PH - Filippine 7
AU - Australia 6
JO - Giordania 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
AZ - Azerbaigian 5
BG - Bulgaria 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
EG - Egitto 5
ES - Italia 5
JM - Giamaica 5
MA - Marocco 5
PY - Paraguay 5
SA - Arabia Saudita 5
BO - Bolivia 4
DZ - Algeria 4
EU - Europa 4
IR - Iran 4
KZ - Kazakistan 4
NG - Nigeria 4
SN - Senegal 4
CH - Svizzera 3
ET - Etiopia 3
HN - Honduras 3
HU - Ungheria 3
KE - Kenya 3
KR - Corea 3
MY - Malesia 3
NI - Nicaragua 3
NP - Nepal 3
RO - Romania 3
UZ - Uzbekistan 3
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
KH - Cambogia 1
LB - Libano 1
MK - Macedonia 1
MR - Mauritania 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
SR - Suriname 1
Totale 11.280
Città #
Dallas 783
Fairfield 741
Ashburn 697
Woodbridge 500
Houston 417
Singapore 347
San Jose 330
Chandler 313
Seattle 297
Jacksonville 252
Cambridge 247
Wilmington 223
Milan 220
Ann Arbor 185
Hong Kong 180
Council Bluffs 136
Nyköping 136
Beijing 115
Roxbury 80
Nanjing 64
New York 63
Lawrence 60
Lauterbourg 58
Des Moines 55
Los Angeles 52
Rome 52
Munich 51
Boardman 48
Bari 41
Santa Clara 40
São Paulo 38
Brooklyn 37
Abidjan 36
Ho Chi Minh City 34
Dong Ket 32
London 32
San Diego 30
Inglewood 29
Princeton 28
Toronto 26
Hanoi 24
Buffalo 20
Dearborn 19
Nanchang 19
Hebei 18
Chicago 17
Columbus 17
Jiaxing 17
Denver 16
Shenyang 16
Tokyo 16
Miano 15
Phoenix 15
Tianjin 15
Falls Church 14
Moscow 14
Atlanta 13
Brussels 13
Rio de Janeiro 13
Brasília 12
Helsinki 12
Norwalk 12
Turin 12
Warsaw 12
Changsha 11
Figino 11
Frankfurt am Main 11
Montreal 11
Amsterdam 10
Baghdad 10
Belo Horizonte 10
Nuremberg 10
Orem 10
San Francisco 10
Dublin 9
Foggia 9
Turku 9
Charlotte 8
Falkenstein 8
Istanbul 8
Johannesburg 8
Marseille 8
Paris 8
Chennai 7
Guayaquil 7
Pune 7
Redwood City 7
Venezia 7
Indiana 6
Jakarta 6
New Delhi 6
Shanghai 6
Washington 6
Ankara 5
Augusta 5
Bogotá 5
Bologna 5
Boston 5
Miami 5
Mumbai 5
Totale 7.755
Nome #
1 - 10 of 10 One page. 1: Molecular analysis in a family presenting with a mild form of late-onset autosomal dominant chronic progressive external ophthalmoplegia 1.036
A case of vacuolar myopathy during the course of chronic hepatitis C 794
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study 241
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 202
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B 199
Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort 191
A rare case of multiple sclerosis and McArdle disease 190
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 186
Leber's hereditary optic neuropathy, intellectual disability and epilepsy presenting with variable penetrance associated to the m.3460G>A mutation and a heteroplasmic expansion of the microsatellite in MTRNR1 gene - case report 180
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 178
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients 177
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of Multiple Sclerosis 169
A new locus on 3p23-p25 for an autosomal-dominant limb-girdle muscular dystrophy, LGMD1H 168
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis 160
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. 157
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis. 155
. Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications 154
Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis. 152
Hirayama disease: the importance of an early diagnosis 150
Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype 150
Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium 146
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease 144
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy 144
Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. 144
Referral bias in ALS epidemiological studies 142
Elevated plasma homocystein levels in patients with Amyotrophic lteral sclerosis 134
Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias 134
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy 132
Molecular analysis in a family presenting with a mild form of late-onset autosomal dominant chronic progressive external ophthalmoplegia 128
Is Frontal Assessment Battery a useful instrument to detect cognitive impairment in ALS?. 127
Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy 126
Low serum urate levels are associated to female gender in multiple sclerosis patients. 124
L-Dopa Related Hyperhomocysteinemia: A Possible Mediator of Toxicity?. 122
Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study 121
Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry. 120
Cerebellar ataxia as atypical manifestation of the 3243A > G MELAS mutation 120
The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. 118
Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration during COVID-19 Pandemic: Results from Southern Italy 118
Efficacy of riluzole: who are the patients enrolled in the studies? 117
Late-onset Leber hereditary optic neuropathy mimicking Susac's syndrome 116
A novel mutation in the LRSAM1 gene in a family with early onset autosomal dominant Charcot-Marie-Tooth type 2P 115
Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients 115
"A case report of association between amyotrophic lateral sclerosis (asl) and diffuse lewy bodies dementia (dlbd)" 114
CMT2A harboring mitofusin 2 mutation with optic nerve atrophy and normal visual acuity 114
Incidence of amyotrophic lateral sclerosis in Europe 110
Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions 108
A 71-nucleotide deletion in the periaxin gene in an Italian patient with late-onset slowly progressive demyelinating CMT 108
Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration 107
Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review 106
Hyperhomocysteinemia in movement disorders: Current evidence and hypotheses 105
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia 103
Inclusion of motor evoked abnormalities in amyotrophic lateral sclerosis: a diagnostic algorithm to early classify lower motor neuron phenotypes 102
null 101
null 100
ALS DEMENTIA INCIDENCE IN AN ASL COHORT STUDY:RESULTS FROM A POPULATIION-BASED REGISTER (SLAP) 100
Coffee and amyotrophic lateral sclerosis: a possible preventive role. 98
null 95
Gender Differences of Cortical Thickness in Amyotrophic Lateral Sclerosis 93
DISABILITA' VISIVA NELLA NEUROPATIA OTTICA EREDITARIA DI LEBER. DALLA DIAGNOSI PRECOCE ALLA RIABILITAZIONE 88
Pathogenesis of NeuroCOVID: Views after Two Years of Pandemic 80
null 78
null 75
Unusual clinical presentation of a patient carrying a novel single 1.8 kb deletion of mitochondrial DNA 75
null 74
null 73
null 72
Prognosis of amyotrophic lateral sclerosis in Southern Italy: Results from a population-based registry, SLAP (Sclerosi Laterale Amiotrofica-Puglia) 72
null 69
IS FRONTAL ASSESSMENT BATTERY A USEFUL INSTRUMENT TO DETECT COGNITIVE IMPAIRMENT IN ASL? 67
null 65
null 64
null 64
“Sclerosi Laterale Amiotrofica e demenza a Corpi di Lewy: descrizione di un caso” 63
null 62
IDIOPATHIC REM SLEEP BEHAVIOUR DISORDER AS A PRECURSOR OF NEURODEGENERATIVE DISEASE 61
null 61
null 60
Cortical Thinning in Frontal Lobes Is Relate with Faster Progression of Amyotrophic Lateral Sclerosis 59
null 56
null 54
null 53
null 47
null 46
Split-elbow sign in the PRO-ACT and Southern Italy ALS cohorts: a potential marker of disease severity and lower motor neuron involvement? 26
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy 22
AChR+ Ocular Myasthenia and Facial Hemispasm: A Case Report of Unusual Association and Botulinum Toxic Type A Safety and Efficacy 18
King's college progression rate at first clinical evaluation: A new measure of disease progression in amyotrophic lateral sclerosis 18
A Clinical Scale for Rating the Severity of Bulbar Lower Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis 17
Subclinical upper motor neuron involvement at the diagnosis may predict disease progression in a cohort of lower motor neuron syndromes from Southern Italy 16
Nerve conduction study on the split-hand plus index in Amyotrophic lateral sclerosis: correlations with lower motor neuron impairment 15
Mapping lower-limbs muscle vulnerability in patients with ALS: The role of upper and lower motor neurons 14
Deep Learning-based Approach for Brainstem and Ventricular MR Planimetry: Application in Patients with Progressive Supranuclear Palsy 14
Sleep and circadian rhythm disruptions in behavioral variant frontotemporal dementia 14
148th ENMC international workshop on the scientific contributions of the EURALS consortium on amyotrophic lateral sclerosis 14
Actigraphy validation in behavioral variant frontotemporal dementia. 14
Data-Driven SuStaIn Model of Disability Progression in Amyotrophic Lateral Sclerosis 13
Magnetic resonance metrics to evaluate the effect of therapy in amyotrophic lateral sclerosis: the experience with edaravone 13
Reduction of Sniff Nasal Inspiratory Pressure (SNIP) as an Early Indicator of the Need of Enteral Nutrition in Patients with Amyotrophic Lateral Sclerosis 12
Concomitant myotonic dystrophy type 1, CIDP-like neuropathy and Hashimoto thyroiditis: a causal link? 12
Nocturnal sleep dynamics alterations in the early stages of behavioral variant frontotemporal dementia 12
Totale 11.362
Categoria #
all - tutte 37.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022488 0 0 0 14 39 69 22 30 52 33 96 133
2022/2023755 106 95 54 75 95 73 7 91 117 7 17 18
2023/2024257 27 54 13 15 24 59 13 3 2 8 8 31
2024/20251.132 41 26 92 47 28 96 95 104 60 50 155 338
2025/20263.818 368 233 743 247 250 135 244 79 888 235 69 327
2026/20271.120 112 95 562 351 0 0 0 0 0 0 0 0
Totale 11.544